JESÚS SILVA-RODRÍGUEZ, PABLO AGUIAR, INÉS DOMÍNGUEZ-PRADO, MICHEL HERRANZ, ÁLVARO RUIBAL 18F-Choline: Is shine-through effect an issue for prostate SUV.

Slides:



Advertisements
Similar presentations
Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD
Advertisements

Harvard Medical School Massachusetts General Hospital.
The Thyroid Incidentaloma
Objective Comparison of direct real-time endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA), PET, CT for detection of mediastinal.
Imaging modalities in prostate cancer
Toward a molecular intra-operative diagnosis of SLN invasion R Garrel 1, V Burcia 1, J Solassol 2, V Costes 3, E Barbotte 4, D DeVerbizier 5, C Cartier.
“International Conference on Clinical PET and Molecular Nuclear Medicine” IAEA - IPET 2007 Bangkok, Thailand 10 to 14 November 2007 C. Suarez, R. Pruzzo,
Clinical Significance of Preoperative 18F-FDG PET Non- Avidity in Papillary Thyroid Carcinoma Do Hoon Koo 1, Ho-Young Lee 2, Kyu Eun Lee 3,4, So Won Oh.
18F- FDG PET/CT in the Diagnosis of Tumor Thrombosis
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Observer Study of Reconstruction Strategies for Detection of Solitary Pulmonary Nodules Using Hybrid NeoTect SPECT Images Xiaoming Zheng, PhD. 20 October,
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
JHSGR 16 th April 2011 Dr Lee Man Kit Derek.  The value of PET in staging adenocarcinoma (e.g. colorectal cancer) is well established Tomoharu T. et.
Application of Positron Emission Tomography ( PET ) in Colorectal Cancer Dr Chan Wai Keung Department of Surgery Ruttonjee and Tang Shiu Kin Hospitals.
Clinical Utility of Combidex in Various Cancers
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
18 F-FET PET Compared with 18 F- FDG PET and CT in Patients with Head and Neck Cancer Present by Intern 羅穎駿 Journal of Nuclear Medicine Vol. 47 No
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
Molecular Cancer Targets Wester H Clin Cancer Res 2007;13:
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99 mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT,
Dual-time point 18F-FDG PET/CT scan: is it always working?
M. Wissmeyer Department of Nuclear Medicine, University of Berne (Inselspital) PET/CT in Radiation Oncology: Current Evidence and Future Perspectives.
1 NOPR 2006: Results and Lessons Learned 2010 Annual AHRQ Conference NOPR 2006: Results and Lessons Learned 2010 Annual AHRQ Conference Bruce E. Hillner,
The Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non- Small Cell Lung Cancer Malcolm Mattes, Salma Ahsanuddin,
Functional Imaging with PET for Sarcoma Rodney Hicks, MD, FRACP Director, Centre for Molecular Imaging Guy Toner, MD, FRACP Director, Medical Oncology.
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
18 FDG PET/CT in the diagnosis of Malignant Peripheral Nerve Sheath Tumours VS Warbey, RE Ferner, JT Dunn, E Calonje, MJ O’Doherty St Thomas’ Clinical.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/2/09.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
EuroMedIm Irène Buvat - May Quantification in emission tomography: challenges, solutions, performance and impact Irène Buvat U678 INSERM,
Early detection of an endometrial cancer on health screening by PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.
Prognostic Value of PET Using 18F-FDG in Hodgkin’s Disease for Posttreatment Evaluation J Nucl Med 2003; 44:1225–1231 Intern 魏敬庭.
Scanner Validation via the SNM Clinical Trials Network Phantom Program Paul E. Christian Molecular Imaging Program Huntsman Cancer Institute University.
FDG PET/CT case report early detection of ovarian cancer NM case conference, chairman: Nan-Jing Peng, MD.
CARATTERIZZAZIONE DI LESIONI DI ORIGINE SCONOSCIUTA SOSPETTE PER LESIONI MALIGNE NEI PAZIENTI PEDIATRICI: POSSIBILE RUOLO DEL 18F-FDG PET/CT A.Cistaro.
Impact of Axial Compression for the mMR Simultaneous PET-MR Scanner Martin A Belzunce, Jim O’Doherty and Andrew J Reader King's College London, Division.
Albert J. Chang, MD, PhD 1 Farrokh Dehdashti, MD 2 Perry W. Grigsby, MD, MS 1 Department of Radiation Oncology 1 Department of Radiology and Nuclear Medicine.
MRI IN PROSTATE CANCER MAHYAR GHAFOORI M.D. Associate Professor of Radiology Tehran University Of Medical Sciences.
PET/MR in Oncology: Non– 18 F- FDG Tracers for Routine Applications R2 丁建鑫.
Nuclear Medicine and PET rev this is now slide 1do not print it to pdf things to do (check off when complete): add revision date to cover page.
Anaplastic thyroid cancer based on ATA guideline for Management of Patients with ATC. Thyroid. 2012;22: R3 이정록.
Reducing excess imaging dose to cancer patients receiving radiotherapy Adam Schwertner, Justin Guan, Xiaofei Ying, Darrin Pelland, Ann Morris, Ryan Flynn.
Nick Wegner 4/22/10 The Use of CT in Diagnosing Pulmonary Metastases in Osteosarcoma.
Monday Case of the Day A) The treatment was successful: The bremsstrahlung SPECT (Fig 2) indicates that 90 Y was deposited in the tumor. B) The treatment.
IMAGING OF INCIDENTAL ADRENAL LESIONS: PRINCIPLES, TECHNIQUES AND ALGORITHMS Giles W.L. Boland Massachusetts General Hospital Harvard Medical School.
Preoperative staging of hilar cholangiocarcinoma by dual-modality PET/CT. DR SIKANDAR YASHODA HOSPITALS HYDERABAD.
PET Scanner Calibration Using a Small Ga68/Ge68 Source
Authors: Syed H. Jafri ¹, Angel I. Blanco¹, Bonnie A. Labdi², Shan Guo¹. UT Houston department of medicine, Division of Oncology Department of Pharmacy.
Segmentation of 3D microPET Images of the Rat Brain by Hybrid GMM and KDE Tai-Been Chen Department of Medical Imaging and Radiological Science,
The Optimization of Reconstruction Method Reducing Partial Volume Effect in PET/CT 3D Image Acquisition Department of Nuclear Medicine, Samsung Medical.
간담도 암에서의 PET 의 활용 핵의학과 홍일기. 18 F-FDG PET: Warburg effect.
A prospective study of PET/CT in initial staging of small-cell lung cancer : comparison with CT, bone scintigraphy and bone marrow analysis B. M. Fischer1,
J Cho, G Ibbott, M Kerr, R Amos, and O Mawlawi
Nuclear imaging for prostate cancer: What’s new?
Klinikum rechts der Isar, Technische Universität München
CORRELATION BETWEEN AREAS OF HIGH FDG UPTAKE ON PRE-TREATMENT PET/CT AND PREFERENTIAL SITES OF LOCAL RELAPSE AFTER CHEMO-RADIOTHERAPY FOR HEAD AND NECK.
CORRELATION OF PHYSICAL EVALUATION AND MRI OF CERVICAL LYMPH NODE WITH HISTOPATHOLOGICAL FINDINGS IN ORAL SQUAMOUS CELL CARCINOMA: AN AMBIDIRECTIONAL STUDY.
Zehra Nihal Dolgun, Ahmet Salih Altintas, Cihan Inan, Petek Balkanli
Thursday Case of the Day
Quantitative Nuclear Medicine Imaging
Monday Physics Case of the Day Answers (1 of 3) Paul E
Tuesday Case of the Day Physics History: A B MIP
Whole Body 18F-FDG PET/CT Imaging Staging of Malignant Melanoma:
G. Delso, D. Gillett, W. Bashari, T. Matys,
Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease  Geoffrey M. Graeber, MD*, Naresh.
The impact of 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia  Rebecca.
Evaluation of Average CT to reduce the artifact in PET/CT
Presentation transcript:

JESÚS SILVA-RODRÍGUEZ, PABLO AGUIAR, INÉS DOMÍNGUEZ-PRADO, MICHEL HERRANZ, ÁLVARO RUIBAL 18F-Choline: Is shine-through effect an issue for prostate SUV quantification?

Introduction: Imaging on prostate cancer Imaging techniques such as CT, MRI and TRUS are useful, but have demonstrated limited sensitivity PET and PET/CT could potentially increase accuracy for the diagnosis of prostate cancer FDG showed limited sensitivity for the detection of prostate carcinomas and local recurrence NEED: New radiotracers Farsad et al: “PET/CT and choline: diagnosis and staging.”. Q J Nucl Med Mol Imaging. 2012

Introduction: Choline

Biochemical recurrence. Clinically suspected prostate cancer, with multiple negative biopsies. Patient stratification with respect to surgery or radiotherapy. Lymph node and bone metastasis. Biochemical recurrence. Clinically suspected prostate cancer, with multiple negative biopsies. Patient stratification with respect to surgery or radiotherapy. Lymph node and bone metastasis. 11C-choline and 18F-choline are increasingly prescribed for: Introduction: Choline in prostate cancer Schwarzenböck et al: “Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer”. Theranostics. 2012

Introduction: Choline in prostate cancer First clinical studies presented partially controversial results. Detection sensitivity (73%-100%) and specificity (67-98%). NEXT STEP: Diagnosis of primary prostate cancer.

Introduction: SUV in prostate cancer Attempts to use quantitative parameters such as SUV has also delivered mixed and contradictory results QUESTION: Is F18-choline suitable for the use of these quantification values? Tissue18F-Choline SUV Normal prostate tissue Prostate cancer Local Recurrence

Introduction: Shine-Through Liu et al: ”Invalidity of SUV Measurements of Lesions in Close Proximity to Hot Sources due to “Shine-Through” Effect on FDG PET-CT Interpretation” Radiology Research and Practice 2012

Introduction: 11C vs 18F choline The main difference is the early appearance of 18 F-Choline in the urinary tract due to an incomplete tubular re-absorption

Introduction: Shine-Through QUESTION: Is shine-through a problem for the use of SUV measurements in 18F-choline scans?

Methods: Experiment Workflow Our Workflow: 18F Choline Phantom Sinograms Reconstruction Estimated prostate SUVs MonteCarlo simulation (SIMSET) Tomographic reconstruction (STIR) Theo. Prostate SUV Theo. Bladder SUV Comparison Scatter & att correction Silva-Rodriguez et al: “Simulated FDG-PET studies for the assessment of SUV quantification methods”. Rev Esp Med Nucl Ima Mol 2014

Methods: Experiment Workflow

A single patient representing the average Spanish man (172 cm, 76 Kg) was generated using the XCAT phantom*. Methods: Phantom The bio-distribution of choline was derived from literature A hot spot was added in the prostatic left lobe to emulate a primary prostate tumor or local recurrence (24 cm3). (*) Seagars et al: “4D XCAT phantom for multimodality imaging research.” Med. Phys. 2010

Methods: Scanner The simulated scanner geometry was based on the GE Advance Nxi. Attenuation, scatter correction and reconstruction were also based on the protocols performed by this scanner. Silva-Rodriguez et al: “Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of real patient studies” Med Phys 2014

Methods: Simulation and Reconstruction Total injected dose was 370 MBq for all the studies. Studies were simulated for  Lesion SUVs of 3.03 and 6.06  Bladder SUVs of 1.1, 3.03, 7.58, 13.64, SIMSET package was used to perform the simulation. (5 repetitions/point) Sinograms were reconstructed using the STIR library OSEM. (stir.sourceforge.net) SUVmax was measured on the simulated lesion for all the lesions. Total injected dose was 370 MBq for all the studies. Studies were simulated for  Lesion SUVs of 3.03 and 6.06  Bladder SUVs of 1.1, 3.03, 7.58, 13.64, SIMSET package was used to perform the simulation. (5 repetitions/point) Sinograms were reconstructed using the STIR library OSEM. (stir.sourceforge.net) SUVmax was measured on the simulated lesion for all the lesions. Thielemans et al: “STIR: Software for Tomographic Image Reconstruction Release 2”, PMB 2012

Results Theoretical SUV = % +5.6% +19.8% +24.1% +27.4% +41.3%

Results -2.3% +0.1% +0.7% +7.9% +16.2% +23.4% Theoretical SUV = 6.06

Results

Discussion The effect becomes specially relevant when bladder SUV is higher than the lesion SUV, showing a strong dependency on tumor/bladder ratio. Avoiding bladder accumulation is essential for an accurate quantification of lesions on the prostatic region Urinary excretion and high accumulation in the bladder can compromise not only detectability, but also quantification results when using 18F-choline (up to 40%).

Conclusions 11C-choline might be more reliable for quantitative evaluation of the prostatic region If 18F-choline is used, a correction method will be mandatory for the quantitative evaluation of prostate cancer Bladder accumulation of 18F-choline significantly biased the measurements of prostatic lesions SUV

Molecular Imaging Reseach Group INVESTIGADOR PRINCIPAL: Álvaro Ruibal Morell Professor of Radiology and Medical Physics, University of Santiago de Compostela Head of the Nuclear Medicine Department, Santiago University Hospital MIEMBROS DEL EQUIPO Michel Herranz Pablo Aguiar Jesús Silva Julia Cortés Sonia Argibay Virginia Pubul Patricia Fierro Inés Domínguez Miguel Garrido María Pombo Jesús López Alejandro Bejarano

The end